Sound waves aim to tame Huntington's tremors

NCT ID NCT07513844

Recruiting now Symptom relief Sponsor: First Affiliated Hospital of Fujian Medical University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early-stage trial tests whether low-intensity focused ultrasound (LIFU) can safely improve motor symptoms in 24 adults with Huntington's disease. Participants receive ultrasound pulses to a brain region involved in movement control. The study focuses on safety and finding the best pulse frequency, while also measuring changes in movement scores.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Low-intensity focused ultrasound (LIFU) device
What this could lead to: If successful, this could point toward a non-invasive way to ease movement problems in Huntington's disease.
What could go wrong: This is a very early, small safety trial (24 people). It may not show clear benefit, and risks include seizures, mood changes, or brain swelling.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HUNTINGTON DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Huntington disease

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HUNTINGTON DISEASE

Contacts and locations

Locations

Department of Rehabilitation Medicine, The First Affiliated Hospital of Fujian Medical University
RECRUITING

Fuzhou, Fujian, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.